Podcasts about cyanotic

We're getting into the weeds of US industrial this week, discussing a record that captures a very specific early 90s moment, along with some formal experimentation in D.D.T.'s Discomedia, and one which consolidates the strength and range of cyberpunk stalwarts Cyanotic, The Trigger Effect. We're also looking over the solid lineup and new location for this year's Subtance Festival.

Cyanotic Cyanotic was first introduced to rave and hardcore in 1995, but was already addicted to the unique sounds of electronic music at the age of 5, influenced by Jean-Michel Jarre's Oxygène album. Since 2015 he has been a member of Death Noize Clan Hungary and since 2024 he has been a member of Hard Session Events, a group based in Austria. His sets are dominated by Early and Millenium sounds - but he also likes to play dark and industrial sounds. Social media: https://www.facebook.com/profile.php?id=100071372976231 Tracklist: 1. Iridium - We Are Alive 2. Ophidian - Silver '22 (The Name Of The Wolf) 3. DJIPE - No More Voices (HVRDTONIC Kick edit) 4. RVOLT - Out Of Control 5. The 3Eyed - Demons In Us 6. The Outside Agency & Ophidian - Return Of The Silence 7. eDUB Ft. Igneon System - Shotgun 8. Ophidian - Dead Air 9. Vein - Ultimate Seduction 10. Vein & The Satan - Synthetic Delight 11. The Outside Agency & Ophidian - Church Of The Silence 12. The Satan - Get The Fuck Up (Original mix) 13. Ophidian - Silver (Extended mix) 14. Ophidian - Lynched (Tymon remix) 15. Forbidden Society & Deathmachine - Rude 16. The Satan - Nothing 17. DJIPE & The Purge - Reset 18. RVOLT & Igneon System - Fucking Noise 19. Ophidian - Angel (Millennium DJ edit) 20. Igneon System & Karbyde - Triggerfinger 21. Industrial Twins - Suppression 22. Shinra Tensei - Move 23. Ophidian & Minkz - The Void (Fade)

This episode covers cyanotic heart disease.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/cyanoticheartdisease/ Books can be found at https://zerotofinals.com/books/Questions can be found at https://members.zerotofinals.com/dashboardThe audio in the episode was expertly edited by Harry Watchman.

This episode covers cyanotic heart disease.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/cyanoticheartdisease/ Books can be found at https://zerotofinals.com/books/Questions can be found at https://members.zerotofinals.com/dashboardThe audio in the episode was expertly edited by Harry Watchman.

Live from Cold Waves III at Metro, Chicago in 2014. Cyanotic Set: 1. Signal the Machines 2. Order Out of Chaos 3. Transhuman 4. Deface 5. Disconnect Me 6. Alt Machine 3Teeth Song: 7. Master of Decay

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Other Cyanotic Congenital Heart Defects⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠from the Cardiovascular section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets Linkedin: https://www.linkedin.com/company/medbullets

Commentary by Dr. Valentin Fuster

Download for FREE today -  special Mnemonics Cheatsheet - so you can be SURE that you have that Must Know information down:  bit.ly/nursing-memory   Outline The 4 T's T-Tetralogy of Fallot T-Truncus Arteriosus T-Transposition of the Great Vessels T-Tricuspid Atresia Description Cyanotic heart defects are a group of congenital heart defects that result from deoxygenated blood by-passing the lungs and going into systemic circulation. Tetralogy of Fallot includes 4 anatomical abnormalities that are pictured below. Truncus Arteriosus is a condition where the pulmonary trunk and aorta don't properly divide in development. This results in one large vessel carrying mixed blood to the heart, lungs, and systemic circulation. Transportation of the Great Vessels is a condition where vessels are swapped or may be in abnormal positions. Tricuspid Atresia is a condition where there is no tricuspid valve, which leads to an undersized or absent right ventricle.

It's New Tunesday: new releases from the past week! Give the bands a listen. If you like what you hear, support the bands! Today's episode features new releases by Nightcrawler & Deus Ex Lumina, All Systems Out, IIOIOIOII, Electra Black, Kim Lunner, Carlos Suero, Darkness On Demand, Yuzna, Comando Suzie, London Sadness, Sapphira Vee, DSM-V, Corlyx, Petrified Entity, Sad Madona, Claustraphobia, Xibling, Lux Fênix, Das Noir, Slichtnacht, Chem, Ultimate Soldier, Alien Vampires, Cyanotic, Negant, Blackbook, Maschine Brennt, Current One, Sonum Unum, can7say, Parralox, The Farm, Midnight Fighters, and Just Scott!

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Other Cyanotic Congenital Heart Defects⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Cardiovascular section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Cyanotic got sick and had to reschedule, so we'll end Season 5 with a special Thundercats reading! It's a live AUDIENCE PARTICIPATION "Find Your Fate" event with 1985's "The Thundercats and The Ghost Warrior"! 3pm Eastern Standard Time

$5 Q-BANK: https://www.patreon.com/highyieldfamilymedicine Intro 0:30, Fetal circulatory system 2:00, Persistent fetal circulation 6:38,  Patent ductus arteriosus 8:02, Differential cyanosis 8:40, CCHD screening 9:24, Common themes 10:39, Non-cyanotic heart defects 13:26,  Ventricular septal defects 14:08, Atrial septal defects 15:35, Eisenmenger syndrome 16:28, Aortic and pulmonary stenosis 17:42, Coarctation of the aorta 18:42, Double aortic arch 19:53, Interrupted aortic arch 21:07, Cyanotic heart defects 21:34,  Tetralogy of Fallot 23:39, Transposition of the great arteries 28:03, Hypoplastic left heart syndrome 29:47, Persistent truncus arteriosus 31:09, Partial and total anomalous pulmonary venous connection 33:01, Scimitar syndrome 35:04, Tricuspid and pulmonary atresia 36:03, Prostaglandin E1 indications 36:31, DiGeorge syndrome 38:08, CHARGE syndrome 38:42, Dextrocardia 39:06, Situs inversus and total situs inversus 39:16, Ebstein anamoly 40:04, Noonan syndrome 40:34, Turner syndrome 41:11, Down syndrome 41:28, Marfan syndrome 40:52, Congenital heart blocks 43:03, Practice questions 43:27

Interview with Sean Payne / Music by Cyanotic Video Interview - https://youtu.be/F9G1zlzXWGQ Songs: 1) Survival Instincts [2016] 2) Alt Machine [2010 Jamie Duffy Mix] 3) Borderliner v2

There are generally 3 main congenital heart diseases presentations that young children between ages of 0 days to about 3 months will present with.  Often times you will see experts split these congenital heart lesions into 2 categories: Cyanotic vs Acyanotic lesions. Either is an acceptable approach as long as you split the acyanotic lesions ... Read more The post REBEL Crit Cast Ep5.0 – Conquering Congenital Cardiac Lesions appeared first on REBEL EM - Emergency Medicine Blog.

Today we'll be covering Cyanotic Congenital Heart Disease (CHD), going along with this month's theme, Cardiology. If you haven't listened to our podcast before, each week we have a case-based discussion about a medical topic to help you study for the pediatric medicine board exam. Episodes are released every weekend, and the case is then reviewed and reinforced on social media throughout the week.   Follow the podcast on social media: Facebook- @portablepeds (www.facebook.com/portablepeds) Twitter- @portablepeds (www.twitter.com/portablepeds)   We'd love to hear from you via email at portablepeds@gmail.com!   Also, feel free to visit our website, www.portablepeds.com, for more content.   Today's Case:   A mother with scant prenatal care gives birth.  Almost immediately following delivery, the infant is cyanotic.  An ABG is obtained, and the PaO2 is 35mmHg.  The infant is exposed to 100% FiO2 for 10 minutes, and a repeat ABG is obtained.  The PaO2 remains at 35mmHg.  A chest x-ray is obtained and demonstrates an “egg on a string” appearance.  An echocardiogram confirms the diagnosis, and the patient is taken emergently for an atrial balloon septostomy until definitive surgical correction can be prepared.  What is the most likely underlying lesion/lesions? A VSD, an overriding aorta, right ventricular outflow obstruction, and right ventricular hypertrophy Parallel pulmonary and systemic circulation A common truncal outflow tract and truncal valve Abnormal return of the pulmonary veins Absence of the tricuspid valve   We would like to give an enormous thank you to Zack Goldmann for designing this podcast's logo and accompanying artwork. You can find more of his work at www.zackgoldmann.com.   The intro and outro of this podcast is a public domain song obtained from scottholmesmusic.com.   Intro/Outro- Hotshot by Scott Holmes   Disclaimer: This podcast is intended for healthcare professionals. The information presented is for general educational purposes only and should NOT be used as professional medical advice or for the diagnosis or treatment of medical conditions.   The views and opinions expressed do not represent the views and opinions of our employer or any affiliated institution. Expressed opinions are based on specific facts, under certain conditions, and subject to certain assumptions and should not be used or relied upon for any other purpose, including, but not limited to, the diagnosis or treatment of medical conditions or in any legal proceeding. Full terms and conditions can be found at portablepeds.com.   Thanks for listening! As always, please Rate and Review this podcast on Apple Podcasts, Facebook, or your favorite podcasting platform. Also, Subscribe to get all the latest episodes, and Share this episode with someone you think would enjoy it! Hope to see you real soon!

This week's podcast features author Nicholas Mills and Guest Editor Allan Jaffe as they discuss the article "High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial." (https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.052380) Dr. Carolyn Lam: Welcome to Circulation On The Run, your weekly podcast summary, and backstage pass to the journal and its editors. We're your co-hosts. I'm Dr. Carolyn Lam, Associate Editor from the National Heart Center and Duke-National University of Singapore. Dr. Greg Hundley: And I'm Dr. Greg Hundley, Associate Editor/Director of the Pauley Heart Center and VCU Health in Richmond, Virginia. Well, Carolyn, this week's feature, we're going to examine cardiac troponin, high-sensitive cardiac troponin, and its association with myocardial infarction. But first, before we get to that, how about we grab a cup of coffee and start in and review some of the other articles in the issue? Would you like to go first? Dr. Carolyn Lam: I would love that. The first paper brings up the problem of stroke, remaining a devastating complication of transcatheter aortic valve replacement or TAVR. Now, this stroke risk has persisted despite refinements and the technique and increased operator experience, while cerebral embolic protection devices have been developed to mitigate this risk data regarding their impact on stroke and other outcomes after TAVR are limited. Dr. Carolyn Lam: Dr. David Cohen from Cardiovascular Research Foundation in New York and colleagues performed an observational study using data from the STS-ACC TVT registry, including more than 123,000 patients from almost 600 sites who underwent elective or urgent transfemoral TAVR between January 2018 and December 2019. Dr. Greg Hundley: Wow, Carolyn, this sounds like a really good use of the registry. What were the results? Dr. Carolyn Lam: Indeed, in this nationally representative observational study, the authors did not find an association between embolic protection device use for TAVR and in-hospital stroke in their primary instrumental variable analysis. And that's a technique designed to support causal inference from observational data with site-level preference for embolic protection device use within the same quarter of the procedure as the instrument. Dr. Carolyn Lam: However, they found a modestly lower risk of in-hospital stroke in their secondary propensity weighted analysis. These findings provide a strong basis for large-scale randomized control trials to really test whether embolic protection devices provide meaningful clinical benefit for patients undergoing TAVR. And this is discussed in a nice accompanying editorial by Dr. Tam and with Wijeysundera from University of Toronto. Dr. Greg Hundley: Very nice Carolyn. Well, my first paper comes to us from Professor Hua Zhang from Shanghai Children's Medical Center. Cyanotic congenital heart disease is a complex pathophysiological condition involving systemic chronic hypoxia and some cyanotic congenital heart disease patients are chronically hypoxic throughout their lives which heightens their risk of heart failure as they age. Dr. Greg Hundley: Hypoxia activates cellular metabolic adaptation to balance energy demands by accumulating hypoxia-inducible factor 1-Alpha. And Carolyn, this study aims to determine the effect of chronic hypoxia on cardiac metabolism and function in cyanotic congenital heart disease patients and its association with age. The authors investigated the role of hypoxia-inducible factor 1-Alpha in this process, and the potential therapeutic targets for this were explored. Dr. Carolyn Lam: What did they find Greg? Dr. Greg Hundley: In cyanotic congenital heart disease patients maladaptation of cardiac metabolism occurred during puberty, along with impaired cardiac function. In cardiomyocytes, specific HIF1-Alpha knockout mice, chronic hypoxia failed to initiate the switch of myocardial substrates from fatty acids to glucose, thereby inhibiting ATP production and impairing cardiac function. Increased insulin resistance during puberty suppressed myocardial HIF1-Alpha and was responsible for cardiac metabolic maladaptation in animals exposed to chronic hypoxia. Dr. Greg Hundley: Pioglitazone significantly reduced myocardial insulin resistance, restored glucose metabolism, and improved cardiac function in pubertal chronic hypoxia animals. And so, Carolyn, perhaps future studies could test whether pioglitazone administration during puberty might improve cardiac function in cyanotic congenital heart disease patients. And this article is nicely accompanied by an editorial from Professor Ghofrani. Dr. Carolyn Lam: That's really interesting. For the next paper we're going from cyanotic congenital heart disease to plain old hypertension asking the question, What is the association of blood pressure classification using the 2017 ACC/AHA blood pressure guideline with risk of heart failure and atrial fibrillation? Well, this question was addressed by Dr. Kaneko and colleagues from University of Tokyo who performed analysis using a nationwide health claims database collected in the JMDC claims database between 2005 and 2018. Now note, this was more than 2 million patients followed for a mean of more than a thousand days in whom more than 28,000 incident heart failure, and more than 7,700 incident atrial fibrillation events occurred. Dr. Greg Hundley: Carolyn, this is a really large cohort a lot of events. What did they find here? Dr. Carolyn Lam: Among adults not taking anti-hypertensive medications and with no prevalent history of cardiovascular disease, stage one and stage two hypertension, according to the 2017 ACC/AHA blood pressure guidelines was associated with a higher incidence of heart failure and atrial fibrillation. The population attributable fractions for heart failure associated with stage 1 and stage 2 hypertension were 23.2% and 51.2% respectively. The population attributable fractions for atrial fibrillation associated with stage 1 and 2 hypertension were 17.4% and 34.3% respectively. The categorization based on 2017, ATC/AHA blood pressure guidelines may improve risk stratification for identifying adults at high risk for heart failure and atrial fibrillation. Dr. Greg Hundley: Wow Carolyn. Really useful data and something I love about our journal, a transition from a large cohort study on hypertension, and now we're going to delve into the world of preclinical science and talk about myocardial hypertrophy. Carolyn, exercise can induce physiological myocardial hypertrophy and former athletes can live five to six years longer than non-athletic control suggesting a benefit after regression of physiological myocardial hypertrophy. Dr. Greg Hundley: Accordingly, these authors led by Professor Yulin Liao from Nanfang Hospital and Southern Medical University hypothesized that anti-hypertrophic memory exists after physiologic myocardial hypertrophy has regressed increasing myocardial resistance to subsequent pathological hypertrophic stress. In this study, C57BL, six mice were submitted to 21 days of swimming training to develop physiological myocardial hypertrophy. Then after termination of the swimming events and exercise, the physiological myocardial hypertrophy regressed within a week. And these physiological myocardial hypertrophy regression mice termed the exercise preconditioning group or HP, and then sedentary mice as a control group underwent transverse aortic constriction, or a sham operation and were observed for four weeks. Dr. Greg Hundley: Finally, in these two groups, cardiac remodeling and function were evaluated using echocardiography invasive left ventricular hemodynamic measurements and histological analysis. Dr. Carolyn Lam: Wow. Exercise induced and I hypertrophic memory in the heart. That is so cool. Greg, could you summarize what they found? Dr. Greg Hundley: Yeah. And how about that exercise stimulus? The mice were swimming. Carolyn, these authors found that exercise-induced physiological myocardial hypertrophy can produce cardioprotective effect. And this cardioprotective effect continues to exist after the physiological myocardial hypertrophy subsides. And it's termed a phenomenon exercise hypertrophy preconditioning. Dr. Greg Hundley: Now, mechanistically, the investigators found that exercise hypertrophy preconditioning up regulates the expression of the long noncoding RNA Mhrt779 by increasing the three methylation of histone 3 at the A4 promoter of Mhrt779. Dr. Greg Hundley: Carolyn, also cardiac overexpression are knocked down of Mhrt779 respectively enhanced or weakened the anti hypertrophy effect of exercise hypertrophy preconditioning. The clinical implications of this research are that these results will likely stimulate further research into the mechanisms of exercise hypertrophy preconditioning, and Mhrt779 may be a potential therapeutic target for myocardial heart hypertrophy and heart failure in clinical practice. Dr. Carolyn Lam: Wow. Thanks so much, Greg. That was an incredible summary. Dr. Carolyn Lam: Let me tell you what else is in today's issue. There's an exchange of letters amongst doctors Mehmood Donkor, and Westermann regarding the article “Left Ventricular Unloading is Associated with Lower Mortality in Cardiogenic Shock Patients Treated with Venal Arterial Extracorporeal Membrane Oxygenation.” There's an ECG Challenge by Dr. Bhasin regarding “A Young Woman with Palpitations. Is It a Poison or Is It a Reality?” Dr. Carolyn Lam: In Cardiology News by Tracy Hampton, she describes new research, revealing mechanisms behind exercise-induced heart damage, new details behind muscle injury repair, and new insights on plasma membrane rupture during cell death. Very interesting. A new section there. There's a Perspective piece by Dr. Passman on “'Pill in the Pocket?' Anticoagulation for Atrial Fibrillation. Is That Fiction, Fact, or Foolish?” Dr. Greg Hundley: Great, Carolyn. Well also in the mailbag, there's a Frontiers and medicine piece from Professor Rohatgi entitled “HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.” And then finally, Carolyn, a Research Letter from Professor Felker, entitled Probabilistic Re-adjudication of Heart Failure Hospitalization: Events in the Paragon-HF Study.” Well, Carolyn, what a great group of articles summarized. How about now we proceed to that feature discussion? Dr. Carolyn Lam: Let's go Greg. Dr. Greg Hundley: Well, listeners. We are now to our featured discussion today and we have with us one of our associate editors who has submitted a paper, Dr. Nick Mills from Edinburgh, Scotland. And then we have a guest editor. Sometimes he's been a feature author, but now he's serving as a guest editor, Dr. Alan Jaffe from Rochester, Minnesota. Welcome gentlemen. Dr. Greg Hundley: Well, Nick, could you start us off first and describe for us the hypothesis that you wanted to test, and then maybe also provide a little bit of context or background around the study that you and your team have just performed. Dr. Nicholas Mills: Thanks, Greg. I've been working for about a decade trying to understand how we can get the value from high-sensitivity cardiac troponin in our clinical practice. We've tried a number of different approaches to implement them for the benefit of patient care that I'm particularly proud of this trial. What we'd recognized that I think with the rollout of these assays across Europe and more recently in America is that they're excellent tests, but they do generate some diagnostic uncertainty in clinical practice. Dr. Nicholas Mills: But as we've got used to using them, we've learned that actually their major strength is that the confidence that they bring in ruling out myocardial infarction rather than ruling it in. And they allow us to make really early decisions often with a single test at the point of arrival, where we can say with absolute confidence that a patient does not have acute coronary syndrome and it's unlikely to have a problem in the next 30 days or one year based on just how low that high sense of high-sensitivity cardiac troponin result is. And I've been a strong advocate for using these tests in that way for some time. But the limitation has been that much of the work in this field has been observational. And so the patients were actually managed accordingly because of uncertain pathways. And there's always been some uncertainty as just how effective they are when in clinical practice, whether using these approaches are safe. And so we designed the Historic Trial to address that definitively in our hospitals in Scotland. Dr. Greg Hundley: Very nice Nick. So what was the study population and what was the design for this Dr. Nicholas Mills: Thanks Greg. So we use an interesting study design set wage cluster, randomized controlled trial, where rather than randomizing individual patients and randomized hospitals in Scotland, in order to do a trial like this, you need very detailed infrastructure because we wanted to enroll every consecutive patient, attending our emergency departments with symptoms, suspicions of acute cardiac syndrome. We embed it so into our care path, which allows our clinicians to enroll patients for us. We were keen to enroll all consecutive patients because we wants to be confident that our findings were truly generalizable at any included patients with complex comorbidities presenting that of ours who were sick unwell, which is often not the case; they've been observational studies. We randomized hospitals and follow up patients with acute coronary syndrome up for a year in order to determine whether the implementation of already changed clinical care and that was safe and did not lead to recurrent and in the future. Dr. Greg Hundley: Very nice. So Nick, in this randomization of hospitals, how many total patients did you encounter and then what were your study results? Dr. Nicholas Mills: So we enrolled 31,492 consecutive patients. I've crossed all seven hospitals implementing our early relapse pathway, reduced length of stay overall in the hospital. By just over three hours, we increased the proportion of patients who are directly discharged home from the emergency department by more than 50%. So that overall 71% of patients attending hospital with possible acute coronary syndrome were able to be discharged from the emergency department rather than being admitted unnecessarily for further investigations. But the critical result was, was that major change in the care pathway safe. We had a non-inferiority design. We had a very small number of safety outcomes at 30 days, and it was difficult to prove non-inferiority, but the event rate favored the implementation there. Dr. Nicholas Mills: They will have pathway with the 0.4% of patients we attend within 30 days of heart attack or dying from heart disease for our implementing it and 0.3% in and crucially, we followed everyone up for a year and were able to demonstrate that the safety outcome was not increased in those that we are able to that pathway one year with absolute confidence. And furthermore, there was no difference in re attendance or an all-cause mortality. We the two different arms of the trial. So we concluded that the early relapse pathway was effective and safe, and that using this approach we'd have major benefits from patients who can avoid unnecessary for healthcare providers in terms of reducing actual cost limitations. Dr. Greg Hundley: Fantastic. Well listeners, we're now going to turn to our guest editor, Dr. Alan Jaffe, and Alan, could you help us put into perspective these new data regarding high sensitivity, proponent, and also comment what attracted you to this article so much so that you feel it's needs to be published and circulated worldwide in the literature? Dr. Allan Jaffe: One of the important areas in the field of biomarkers is the movement just finally occurring. And Nick has been the forefront of this, of starting to do randomized trials. Observational data is just that it's observational. The patients are not created based on the information that is by the biomarkers. Patients can be missed if you're missing a sample, you exclude those patients. In addition, most observational trials, try and get informed consent. And by getting informed consent often miss the sickest patients. So what's desperately needed by the field. And which is just now starting with two or three ongoing randomized trials is just that a randomized trial where the investigators are forced to use the data, to manage the patient. And by using the step wedge design that Nick and his group has used in other trials as well, they guarantee that they don't miss patients either. Dr. Allan Jaffe: So that it's comprehensive and takes all into account. This is terribly important to then validate things like in this instance, the rule-out pathway. And I think these data do substantially confirm the fact that a single sample rule-out strategy using the cutoff value that Nick had previously established as optimizing the percentage of the population that can be included works well. It is unfortunate that the way in which they design their trial mist and design their non-inferiority outcome for safety was such that they ended up not finding significance to that. But I agree with Dr. Mills in the sense that the outcome adverse effects were so low, that despite that I think there's very important and reasonable data that this strategy is also safe. Dr. Greg Hundley: Very good. Well, Nick, thinking forward, what do you feel is the next study that needs to really be performed in this area? Dr. Nicholas Mills: I completely agree with everything Alan said. I think there's lots of really interesting approaches to find a group diagnosis, risk stratification of this really common condition. We need trials that demonstrate these approaches actually influence care and outcomes. For me, the challenge remains how to really harness these great tests to route the ruler of my cognitive function. I run about ads of patients with elevated cardiac troponin added due to an underlying condition that is an acute coronary syndrome. And we're starting to think about ways in which we can individualize our decision-making a little bit moving to walk away from binary thresholds, because values are influenced by age, by sex, by comorbidities like renal disease and preexisting heart failure about heart disease. Dr. Nicholas Mills: And by incorporating some of these patient factors into the interpretation of cardiac troponin. I think we can give clinicians better guidance on who to treat early with antiplatelet therapies and who needs invasive investigation than just simply saying that the troponin concentration is all positive or negative. And it's our challenge, I think, is how to harness that information, make it workable in clinical practice, and then demonstrate that by doing so we actually target effective therapies better, and that it makes a difference for patient care. So this is where we're working on at the moment. And I hope that in due course, we'll be able to do randomized trials in this space and that will move things forward again. Dr. Greg Hundley: Alan, do you have anything you'd like to add to that? Dr. Allan Jaffe: Yes. I think we're in a new era. We are finally starting to see there are now two or three randomized trials. It is time that the biomarker diagnostic studies graduate to a higher level of evidence, meaning randomized controlled trials. Nick is leading the way in that regard and I suspect and hope that subsequent trials, although observational trials may help inform which ones we should do, but that subsequent trials will continue to be randomized and generate the more robust data that randomized trials are capable of generating. Dr. Greg Hundley: Well, thank you both. And Nick, thank you for bringing us this research and also Alan, for evaluating it and providing this commentary today. It's quite exciting to have really this new information produced from a randomized trial, which evaluated the utility of a low high sensitivity treponema value in patients presenting to hospitals with chest pain syndromes. Well, on behalf of Carolyn and myself, we want to wish you a great week and we will catch you next week on the run. This program is copyright of the American Heart Association 2021. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association for more visit ahajournals.org.  

Become a member of the Say You Love Satan Army today! Join us! www.patreon.com/sayyoulovesatanpodcast This episode: - Spasms (1983) - Funeral Home (1980) - An Ideal Place to Kill (1971) - Trapped Alive (1988) - Blood Tide (1982) - Deadly Manor (1990) - Don't Panic (1988) - Psycho Goreman (2020) *outro track "Keep on Keepin' on" by Cyanotic from the 2019 "The Trigger Effect". The podcast you are about to listen to is an account of the tragedy that befell four lower level low-lives sometime in the 1980s. Join us every week for an 80s horror overdose!!!!! website: www.sayyoulovesatanpodcast.com email: sayyoulovesatanpodcast@gmail.com Please rate, review, and subscribe on iTunes! instagram: sayyoulovesatanpodcast T-shirts, stickers, and a collection of ghoulish garb is available now at our Redbubble store! www.redbubble.com/people/sayyoulovesatan artwork: Sam Heimer

Presentation and management of cyanotic congenital heart disease

Big Black – “He’s a Whore”, 1987. Automatic – “Mind Your Own Business”, 2019. Gang of Four – “To Hell With Poverty”, 1981. Kas Product – “Never Come Back”, 1982. Pigface – “Cutting Face”, 1993. 16 Volt – “Motorskill”, 1995. Cyanotic – “Signal The Machines (Randolph & Mortimer Remix)”, 2019. A Projection – “Transition”, 2017. Hapax – “Elegy”, 2019. IAMTHESHADOW – “The Skin”, 2018. Body of Light – “Don’t Pretend”, 2019. Night Sins – “Two Headed Dream”, 2019. Bloc Party – “Ares (Villains Remix)”, 2009. SARIN x Imperial Black Unit – “Will To Destroy”, 2019. Website link: https://skullandcrossfades.com/can-i-interfere-with-your-crisis

Live from Bottom Lounge in Chicago, IL - Sept 07, 2012 Setlist: 1) Alt.Machine.Edit 2) Order Out of Chaos 3) F@5h10n v1k+um5 4) Dissonant Dissident https://www.youtube.com/watch?v=gIPw9LhRiU8

We spoke with Dr. Spencer Church, a pediatric resident at Yale University. He goes through the presentation and management of congenital heart diseases. Intro/Outro Music:Inspirational by Rafael KruxLink: https://filmmusic.io/song/5454-inspirational-License: http://creativecommons.org/licenses/by/4.0/

You’re called to the nursery to evaluate a baby with low oxygen saturations who is looking blue. How do you know if it’s cardiac or pulmonary and what can you do to distinguish the two? What steps do you need to take to stabilize this baby?  Luckily, Andi Marmor, MD sits down with UCSF pediatric cardiologist Jeffrey Gossett MD to discuss cyanotic congenital heart disease and answer these questions and so many more. Click Here to view references and show notes

Playlist: violent vicky - circle squareCyanotic - information overloadSeeming - the eyes of extinctionhello moth - a song about honestyConformco - supply and demandaaimon - lowrabbit junk - shadow horizonDevours - off the gridHouses Of Heaven - time apartRhys Fulber - konsumkill minus nine - #1 exportterrorlokaust - condemned to be freeFear Factor - pisschristhago - ezekiel 1.4tyrant of death - proteusSeraphim Shock - shadow realmAnonymus - maquinasBlack Pestilence - hellfire壕Trench - cosmic gravepersefone - aathma

What's he gonna do with all those t-shirts? Jon and Matt get to know bad ass drummer (and good ass guy) Jesse Hunt. Get some history...find out how he is spending his apocalypse...and more! (There might even be a special appearance to catch.) --- Send in a voice message: https://anchor.fm/undetermined-podcast/message Support this podcast: https://anchor.fm/undetermined-podcast/support

Dr. Thomas Fagan, interventional cardiologist in the Department of Pediatric Cardiology at Cleveland Clinic, discusses interventional options, such as PDA and RVOT shunt placements, as alternatives to surgery. The talk was presented at the Cleveland Clinic’s 4th Annual Advances in Pediatric and Congenital Heart Summit focused on Congenitally Corrected Transposition of the Great Arteries. We look forward to the 5th Annual Advances in Congenital Heart Disease at Cleveland Clinic in October of 2020.

It's a true blue rendezvous! Machine noise moguls and angry robot authorities, the mighty Cyanotic sits down with Space Couch to discuss their new album, THE TRIGGER EFFECT, and all things glitchy and scratchy. Come with me if you want to record it live!

This podcast presents an approach to recognizing and managing cyanotic congenital heart diseases in a newborn. Listeners will learn about etiology and pathophysiology, as well as reviewing what investigations and physical exam findings are suggestive of a cyanotic congenital heart disease. This podcast was developed by Shealynn Carpenter and Brie Cawston-Grant, medical students at the University of Alberta, in collaboration with Dr. Jessica Foulds, a pediatrician, and Dr. Lily Lin, a pediatric cardiologist at the University of Alberta.

This episode of CRACKCast covers Rosen’s Chapter 170, Pediatric Cardiac Disorders. This podcast covers cyanotic and acyanotic cardiac defects, the presentation and management of congestive heart failure in pediatric populations, and the management of common arrhythmias in children. A second podcast will release next week detailing other issues in pediatric cardiology. Episode Overview: 1. What is the most common form of congenital heart disease? 2. List 6 Acyanotic and 8 Cyanotic types of CHD. 3. What are the ductal dependent heart lesions? 4. Describe the emergent management of the hypoxic infant with a suspected ductal dependent cardiac lesion. 5. List types of CHD which are most likely to present outside of the neonatal period. 6. What are the anatomic anomalies seen in Tetralogy of Fallot? What is the pathophysiology of a Tet spell and how is it         managed? What is a ductal-dependent ToF? 7. Describe the management of CHF in the infant. 8. List 12 conditions associated with a high risk of developing dysrhythmias. 9. Compare SVT and ST. 10. Describe the management of SVT in the infant/child.

This episode of CRACKCast covers Rosen’s Chapter 170, Pediatric Cardiac Disorders. This podcast covers cyanotic and acyanotic cardiac defects, the presentation and management of congestive heart failure in pediatric populations, and the management of common arrhythmias in children. A second podcast will release next week detailing other issues in pediatric cardiology. Episode Overview: 1. What is the most common form of congenital heart disease? 2. List 6 Acyanotic and 8 Cyanotic types of CHD. 3. What are the ductal dependent heart lesions? 4. Describe the emergent management of the hypoxic infant with a suspected ductal dependent cardiac lesion. 5. List types of CHD which are most likely to present outside of the neonatal period. 6. What are the anatomic anomalies seen in Tetralogy of Fallot? What is the pathophysiology of a Tet spell and how is it         managed? What is a ductal-dependent ToF? 7. Describe the management of CHF in the infant. 8. List 12 conditions associated with a high risk of developing dysrhythmias. 9. Compare SVT and ST. 10. Describe the management of SVT in the infant/child.

Interview with Sean Payne / Music from Cyanotic Songs: 1) Clear A Path 2) Signal The Machines 3) Order Out Of Chaos https://www.facebook.com/Cyanotic/ www.cyanotic.com/ https://glitchmoderecordings.bandcamp.com/ Cold Waves VI: coldwaves.net/ metrochicago.com/cold-waves-vi/ Subscribe to Cold Waves Soundcheck: Apple Podcasts - https://itunes.apple.com/us/podcast/cold-waves-soundcheck/id1006121711?mt=2 Google Play - https://playmusic.app.goo.gl/?ibi=com.google.PlayMusic&isi=691797987&ius=googleplaymusic&link=https://play.google.com/music/m/Iot4zmbdksljqr7tbskdcnthzm4?t%3DCold_Waves_Soundcheck%26pcampaignid%3DMKT-na-all-co-pr-mu-pod-16 RSS Feed - http://feeds.soundcloud.com/users/soundcloud:users:149627566/sounds.rss

Listen to Dr. Thomas Kulik review the physiological causes of cyanosis in the newborn, explain the pathophysiolgoy of some of the most common cyanotic congenital cardiac defects, review diagnostic considerations for these conditions, and describe some therapeutic management strategies. Initial publication: March 8, 2016. Last reviewed: May 13, 2019 Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by Youtube. We apologize for any inconvenience this may cause.

Listen to Dr. Thomas Kulik review the physiology, evaluation, and management of cyanotic congenital cardiac defects. Initial publication: September 16, 2013. Last reviewed: May 16, 2019 Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu Please note: OPENPediatrics does not support nor control any related videos in the sidebar, these are placed by Youtube. We apologize for any inconvenience this may cause.

In anticipation of EM Cases' upcoming episode, Congenital Heart Disease Emergencies we have Dr. Gary Joubert a double certified Pediatric EM and Pediatric Cardiology expert telling his Best Case Ever of a four month old infant who presents with intermittent cyanosis. The Cyanotic Infant can present a significant challenge to the EM provider as the differential is wide, ranging from benign causes such as GERD to life threatening heart disease that may present atypically in a well-appearing child. Dr. Joubert gives us some simple sweet clinical pearls to help us along the way... The post Best Case Ever 47 – Cyanotic Infant appeared first on Emergency Medicine Cases.

In anticipation of EM Cases' upcoming episode, Congenital Heart Disease Emergencies we have Dr. Gary Joubert a double certified Pediatric EM and Pediatric Cardiology expert telling his Best Case Ever of a four month old infant who presents with intermittent cyanosis. The Cyanotic Infant can present a significant challenge to the EM provider as the differential is wide, ranging from benign causes such as GERD to life threatening heart disease that may present atypically in a well-appearing child. Dr. Joubert gives us some simple sweet clinical pearls to help us along the way... The post Best Case Ever 47 – Cyanotic Infant appeared first on Emergency Medicine Cases.

Cardiology Kulik, T Cyanotic Congenital Cardiac Defects Podcast 091613 by OPENPediatrics

Oontzcast Episode 241 Album of the Month : Retrogramme - Feed Released : http://spaceracerecords.com/ part of EKP. http://www.ekproduct.com/ Itunes, amazon, cdbaby http://spaceracerecords.com/releases/feed-2/ http://www.poponaut.de/retrogramme-feed-p-13740.html?language=en Listen to Feed by Retrogramme on @AppleMusic. https://itun.es/us/vUqz8 http://www.cdbaby.com/m/cd/retrogramme2 https://www.amazon.com/gp/product/B012KP8OMS?ie=UTF8&*Version*=1&*entries*=0 Have you ever been fucked over? Broken up with ? Had a bad boss? Cheated on? Lied to? Then this episode of the Oontzcast is for YOU.  Gord and Shibi talk about all things gone awry, in Episode 241 - Be sure to share your stories on our Facebook page .. We also have a new album of the month- Released in March but too good to NOT be an album of the month. Retrogramme is Oontzcast approved! Stay tuned this month as we will be interviewing Retrogramme and getting the nitty gritty on this and any upcoming projects. 01. Retrogramme - Psychosis (featuring Woj Krol of Controlled Collapse) 02. Consolidated- You Suck 03. Gravity Kills - Falling 05. Junksista - Trust No Bitch 06. Imperative Reaction - Giving Up 07. Alien Vampires - Fuck Off and Die 08. Adam Kult - Fuck Them (Suicidal Romance Remix) 09. The Anger Machine- Bytes of Hate On My DNA 10. 16 Volt- Somebody To Hate [Hate Hegel Mix by Cyanotic feat. Jamie Duffy] 11. The Deity - To Suffer 12. Orange Sector - Burn in Hell (Fucking Lies Mix) 13  Nuclear Sun -  Kill em' All (Glitch Mode Mix by Cyanotic)

Cyberage Radio 01.10.2016 : DEATHPROOF , CYANOTIC, SLEETGROUT,NOLONGERHUMAN, COCKSURE, VISCERA DRIP, HAUJOBB,DEAD WHEN I FOUND HER, ALIEN VAMPIRES, GOD MODULE, NITRONOISE (OFFICIAL), DIVERJE, SIRUS, EXTINCTION FRONT, SKINNY PUPPY BLOCK! EHPH, SYNAPSCAPE, CHAINREACTOR, LINGOUF, GJÖLL

Cyberage Radio 01.03.2016 : BEST OF 2015 PT. 2= DEATHPROOF MUSIC, CYANOTIC, NOLONGERHUMAN, LARVA, COCKSURE, EXTIZE, DEAD WHEN I FOUND HER, ALIEN VAMPIRES, GOD MODULE, SIRUS, NITRONOISE (OFFICIAL), DIVERJE, TECHNOLORGY, SKINNY PUPPY BLOCK! SYNAPSCAPE, CHAINREACTOR, MONO-AMINE (OFFICIAL), LINGOUF, GJÖLL

Cyberage Radio 12.13.2015 : NOLONGERHUMAN, CYANOTIC, VISCERA DRIP, PARTICLE SON, BENJAMIN'SPLAGUE, EXTIZE, ALIEN VAMPIRES, GOD MODULE, EXTINCTION FRONT, VPROJEKT, DEAD WHEN I FOUND HER, SIRUS, NITRONOISE (OFFICIAL), DIVERJE, TECHNOLORGY, SKINNY PUPPY BLOCK! SYNAPSCAPE, CHAINREACTOR, DISTEL

Cyberage Radio 11.29.2015 : CYANOTIC, EXTIZE, ALIEN VAMPIRES, COCKSURE , GOD MODULE, DEAD WHEN I FOUND HER, SIRUS, , A INDUSTRYA,NITRONOISE (OFFICIAL), DIVERJE, LICHTBEUGER, AESTHETIC PERFECTION, , TECHNOLORGY, SKINNY PUPPY BLOCK! SYNAPSCAPE, LINGOUF, CHAINREACTOR, DISTEL, VROMB

Cyberage Radio 11.22.2015 : CYANOTIC, EXTIZE, ALIEN VAMPIRES, COCKSURE , GOD MODULE, NITRONOISE (OFFICIAL), DIVERJE, LICHTBEUGER, AESTHETIC PERFECTION, , TECHNOLORGY, SKINNY PUPPY BLOCK! SYNAPSCAPE, LINGOUF, CHAINREACTOR, DISTEL, VROMB

Cyberage Radio 11.15.2015 : CYANOTIC, EXTIZE, SERAPHIM SYSTEM, ALIEN VAMPIRES, , GOD MODULE, NITRONOISE (OFFICIAL), DIVERJE, LICHTBEUGER, AESTHETIC PERFECTION, DIE SEKTOR (OFFICIAL), GENIUS OF NEFARIOUS, TECHNOLORGY, SKINNY PUPPY BLOCK! SYNAPSCAPE, CHAINREACTOR, DISTEL, VROMB

Cyberage Radio 11.08.2015 : CYANOTIC, COCKSURE, SLEETGROUT, BLAKOPZ, CELLDWELLER, ALIEN VAMPIRES, ZOMBIE GIRL, GOD MODULE, NITRONOISE (OFFICIAL), DIVERJE, LICHTBEUGER, AESTHETIC PERFECTION, DIE SEKTOR (OFFICIAL), BENJAMIN'SPLAGUE, TECHNOLORGY, RUINED CONFLICT, SUICIDE COMMANDO, SHIV-R, SYNAPSCAPE, SKINNY PUPPY COMBICHRIST CONCERT WARMUPS/ BLOCK!! CHAINREACTOR, DISTEL, VROMB, FRANK RIGGIO

Cyberage Radio 11.01.2015 : CYANOTIC, COCKSURE, SLEETGROUT, PARTICLE SON, BLAKOPZ, ALIEN VAMPIRES, ZOMBIE GIRL, GOD MODULE, NITRONOISE (OFFICIAL), DIVERJE, LICHTBEUGER, AESTHETIC PERFECTION, DIE SEKTOR (OFFICIAL), BENJAMIN'SPLAGUE,, TERROLOKAUST (TK), TECHNOLORGY, SUICIDE COMMANDO, SHIV-R, SYNAPSCAPE, SKINNY PUPPY CONCERT WARMUPS/ BLOCK!! CHAINREACTOR, DISTEL, VROMB, FRANK RIGGIO

Cyberage Radio 10.25.2015 : CYANOTIC, SLEETGROUT, PARTICLE SON, BLAKOPZ, ALIEN VAMPIRES, ZOMBIE GIRL, GOD MODULE, AESTHETIC PERFECTION, STUDIO-X VS. SIMON CARTER , TERROLOKAUST (TK), TECHNOLORGY, SUICIDE COMMANDO, SHIV-R, SYNAPSCAPE, SKINNY PUPPY BLOCK! CELLDWELLER, LINGOUF, SIAMGDA, CHAINREACTOR, DISTEL, VROMB, FRANK RIGGIO

Cyberage Radio 10.18.2015 : CYANOTIC, SLEETGROUT, PARTICLE SON, BENJAMIN'SPLAGUE, BLAKOPZ, ALIEN VAMPIRES, LARVA, ZOMBIE GIRL, GOD MODULE, AESTHETIC PERFECTION, STUDIO-X VS. SIMON CARTER , TERROLOKAUST (TK), TECHNOLORGY, SUICIDE COMMANDO, SHIV-R, C-LEKKTOR, SYNAPSCAPE, MONO-AMINE (OFFICIAL), SKINNY PUPPY BLOCK! SNOG, CHAINREACTOR, FRANK RIGGIO

Cyberage Radio 10.19.2014 : CYANOTIC, DIVERJE (concert warmups!) SLEETGROUT, NITRONOISE, E-CRAFT, PRE EMPTIVE STRIKE 0.1, W.A.S.T.E., SONIK FOUNDRY, YOUR BUNNY ROT, FREAKYMIND, DISFIGURED MISTRESS SKINNY PUPPY block, MONO-AMINE, SIAMGDA PAUL KENDALL, and more!

Cyberage Radio 10.12.2014 : CYANOTIC, SLEETGROUT, NITRONOISE, MORE MACHINE THAN MAN, E-CRAFT, PRE EMPTIVE STRIKE 0.1, COCKSURE, YOUR BUNNY ROT, DIVERJE, DISFIGURED MISTRESS SKINNY PUPPY block, MONO-AMINE, NEONSOL, PAUL KENDALL, and more!

Cyberage Radio 10.05.2014 : CYANOTIC, SLEETGROUT, NITRONOISE, MORE MACHINE THAN MAN, E-CRAFT, PRE EMPTIVE STRIKE 0.1, COCKSURE, YOUR BUNNY ROT, DIVERJE, FREAKY MIND, SKINNY PUPPY block, MONO-AMINE, LINGOUF, PAUL KENDALL, and more!

Cyberage Radio 09.28.2014 : CYANOTIC, SLEETGROUT, NITRONOISE, MORE MACHINE THAN MAN, E-CRAFT, PRE EMPTIVE STRIKE 0.1, COCKSURE,YOUR BUNNY ROT, DIVERJE, MACHINES ON BLAST, STAHLNEBEL & BLACK SELKET, CYFERDYNE, SKINNY PUPPY block, MONO-AMINE, LINGOUF, PAUL KENDALL, and more!

Cyberage Radio 09.21.2014 : CYANOTIC, SLEETGROUT, NITRONOISE, EVERYTHING GOES COLD, E-CRAFT, SURGYN, COCKSURE,YOUR BUNNY ROT, DIVERJE, MACHINES ON BLAST, STAHLNEBEL & BLACK SELKET, FRONT LINE ASSEMBLY, SKINNY PUPPY block, LINGOUF, PAUL KENDALL, SIAMGDA, and more!

Cyberage Radio 12.09.2012 : CYANOTIC/ ANGELSPIT / MYPARASITES / TRAKKTOR / DIVERJE / INERTIA / SKINNY PUPPY /

Cyberage Radio 12.02.2012 : CYANOTIC / ANGELSPIT/ PANIC LIFT/ MYPARASITES/ TRAKKTOR/ SOLEMN ASSEMBLY / CAUSTIC / SKINNY PUPPY /

Cyberage Radio 11.25.2012 : CYANOTIC / ANGELSPIT/ PANIC LIFT/ SOLEMN ASSEMBLY/ SKINNY PUPPY / SINSECT /

Ever wonder where the name of the show comes from? The answer lies in this episode's featured track. There's also a ton of new music from Left Spine Down, Cyanotic, Killing Joke, Jordan Reyne, Miss Fd, Mindless Faith and The Dreaming. Support these great bands and buy their music! Full show notes and contact info at http://www.aztalanturf.com

According Cameron Phillips in the Pilot of Terminator: The Sarah Connor Chronicles, "The Skynet missile defense system goes online April 19, 2011. Declares war on mankind and triggers a nuclear apocalypse two days later." This is a special Judgment Day edition of Aztalan Turf Podcast featuring music with an end of the world theme and sound bytes from The Sarah Connor Chronicles. Special guest Roxy Bisquaint from http://www.savethescc.com has a special announcement for all Sarah Connor Chronicles fans. Music from Cyanotic, Cwn Annwn, Psy'Aviah, Killing Joke, Nine Inch Nails, Ladytron, Assemblage 23, Concrete Blonde and more. This episode was especially fun to put together and I hope you enjoy! Full show notes are at http://www.aztalanturf.com

Lots of new and (probably) new to you music on this episode. Brand new Cyanotic, tour news for Ink Dot Boy, Crunch Pod goes digital, Shiv-R / Manufactura and HBO's Rome, I:Scintilla.

The novelty of Internet broadcasting hasn't quite worn off and I've created a show I could have never played in my radio days. Every song includes at least one of the 7 Words You Can Never Say on Television. Also on this episode: a review of Faith and the Muse in Minneapolis, some current and upcoming tour info for Assemblage 23, Cattle Decapitation, Ayria and Project Pitchfork, and Unter Null and Cyanotic.

(Photo-Rachel Bertrand) E.S. Day hits the front of Richards(Vancouver) with Conan (lead vocals/guitar) from Vancouver metal mongers…Cyanotic. Ok so mongers isn’t exactly the right choice of words but, they’ve opened for Static-X, Disturbed and Mudvanye to name few. So….fucking heavy. Let’s just leave it at that. DOWNLOAD/LISTEN (MP3) HERE cyanotic.com myspace.com/cyanotic Copyright © 2004-2007 Abort […]